Modeling and Managing the Risks of Measles and Rubella: A Global Perspective Part II
1Kid Risk, Inc., Orlando, FL, USA.
Abstract:
Measles and rubella continue to circulate globally. Complementing Part I of the special issue, this introduction provides a contrast between other global eradication initiatives and the experience with measles and rubella eradication to date. This introduction builds on the syntheses of the literature provided in Part I and it describes the creation and application of a national risk assessment tool and the development of a dynamic disease transmission model to support global efforts to optimally manage measles and rubella globally using vaccines. Currently, efforts to eradicate measles and rubella suffer from the lack of a commitment to global eradication by key stakeholders, despite strong evidence that their eradication represents a better health and financial option than continued control.
Insights
Global measles and rubella eradication efforts are hindered by a lack of stakeholder commitment. Evidence shows eradication is a better health and financial option than continued disease control.
Area of Science:
- Epidemiology
- Public Health
- Vaccinology
Background:
- Measles and rubella remain global health threats, necessitating effective eradication strategies.
- Existing global eradication initiatives offer lessons for measles and rubella control.
- Part I of this special issue provides a comprehensive literature synthesis on the topic.
Observation:
- This introduction contrasts measles and rubella eradication experiences with other global initiatives.
- A national risk assessment tool was developed and applied to support eradication efforts.
- A dynamic disease transmission model was created to optimize global vaccine management for measles and rubella.
Findings:
- Despite strong evidence favoring eradication, key stakeholders lack commitment to global measles and rubella eradication.
- Current control strategies for measles and rubella are less effective and more costly than eradication.
- Vaccine management and risk assessment tools are crucial for advancing eradication goals.
Implications:
- Achieving global measles and rubella eradication requires enhanced stakeholder commitment and strategic resource allocation.
- Implementing advanced modeling and risk assessment tools can significantly improve vaccine-driven disease management.
- Eradication of measles and rubella offers substantial long-term health and economic benefits compared to ongoing control efforts.
Related Concept Videos
Vaccinations
Principles of Disease Surveillance
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Steps in Outbreak Investigation
Models of Health Promotion and Illness Prevention I
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...


